Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Medeiros-Ribeiro

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Clinics (Sao Paulo, Brazil)|April 9, 2022
Chronic inflammatory diseases, subclinical atherosclerosis, and cardiovascular diseases: Design, objectives, and baseline characteristics of a prospective case-cohort study ‒ ELSA-BrasilIsabela M Bensenor, Alessandra C Goulart, Alexandre C Pereira, et al.
Advances in Rheumatology (London, England)|June 8, 2023
Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this conditionClovis Artur Silva, Leonard de Vinci Kanda Kupa, Ana Cristina Medeiros-Ribeiro, et al.
Plos Neglected Tropical Diseases|November 29, 2021
Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseasesAdriana Coracini Tonacio, Tatiana do Nascimento Pedrosa, Eduardo Ferreira Borba, et al.
The Lancet. Rheumatology|February 12, 2026
Recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases in Brazil: a double-blind, randomised, placebo-controlled, phase 4, non-inferiority studyNadia E Aikawa, Ana C Medeiros-Ribeiro, Sandra G Pasoto, et al.
Annals of the Rheumatic Diseases|March 12, 2022
Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseasesNádia Emi Aikawa, Leonard de Vinci Kanda Kupa, Ana Cristina Medeiros-Ribeiro, et al.
Advances in Rheumatology (London, England)|November 25, 2021
Recommendations of the Brazilian Society of Rheumatology for the use of JAK inhibitors in the management of rheumatoid arthritisKarina Rossi Bonfiglioli, Licia Maria Henrique da Mota, Ana Cristina de Medeiros Ribeiro, et al.
Nature Communications|October 3, 2022
Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patientsClovis A Silva, Ana C Medeiros-Ribeiro, Leonard V K Kupa, et al.
Advances in Rheumatology (London, England)|November 20, 2025
Reply to the letter on "Brazilian guidelines for the management of tuberculosis infection in immune-mediated inflammatory diseases: is retesting in latent tuberculosis screening appropriate and safe?"Viviane Angelina de Souza, Ana Luiza Mendes Amorim Caparroz, Virginia Fernandes Moça Trevisani, et al.
Advances in Rheumatology (London, England)|March 21, 2025
Brazilian recommendations for the management of tuberculosis infection in immune-mediated inflammatory diseasesViviane Angelina de Souza, Ana Luiza Mendes Amorim Caparroz, Virginia Fernandes Moça Trevisani, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Clinics (Sao Paulo, Brazil)|April 9, 2022
Chronic inflammatory diseases, subclinical atherosclerosis, and cardiovascular diseases: Design, objectives, and baseline characteristics of a prospective case-cohort study ‒ ELSA-BrasilIsabela M Bensenor, Alessandra C Goulart, Alexandre C Pereira, et al.
Advances in Rheumatology (London, England)|June 8, 2023
Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this conditionClovis Artur Silva, Leonard de Vinci Kanda Kupa, Ana Cristina Medeiros-Ribeiro, et al.
Plos Neglected Tropical Diseases|November 29, 2021
Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseasesAdriana Coracini Tonacio, Tatiana do Nascimento Pedrosa, Eduardo Ferreira Borba, et al.
The Lancet. Rheumatology|February 12, 2026
Recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases in Brazil: a double-blind, randomised, placebo-controlled, phase 4, non-inferiority studyNadia E Aikawa, Ana C Medeiros-Ribeiro, Sandra G Pasoto, et al.
Annals of the Rheumatic Diseases|March 12, 2022
Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseasesNádia Emi Aikawa, Leonard de Vinci Kanda Kupa, Ana Cristina Medeiros-Ribeiro, et al.
Advances in Rheumatology (London, England)|November 25, 2021
Recommendations of the Brazilian Society of Rheumatology for the use of JAK inhibitors in the management of rheumatoid arthritisKarina Rossi Bonfiglioli, Licia Maria Henrique da Mota, Ana Cristina de Medeiros Ribeiro, et al.
Nature Communications|October 3, 2022
Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patientsClovis A Silva, Ana C Medeiros-Ribeiro, Leonard V K Kupa, et al.
Advances in Rheumatology (London, England)|November 20, 2025
Reply to the letter on "Brazilian guidelines for the management of tuberculosis infection in immune-mediated inflammatory diseases: is retesting in latent tuberculosis screening appropriate and safe?"Viviane Angelina de Souza, Ana Luiza Mendes Amorim Caparroz, Virginia Fernandes Moça Trevisani, et al.
Advances in Rheumatology (London, England)|March 21, 2025
Brazilian recommendations for the management of tuberculosis infection in immune-mediated inflammatory diseasesViviane Angelina de Souza, Ana Luiza Mendes Amorim Caparroz, Virginia Fernandes Moça Trevisani, et al.
Pageof 13